Long-term efficacy of ustekinumab with and without concomitant immunosuppressants for Crohn's disease: results from IM-UNITI long-term extension through 2 years

被引：2
|
作者：
Ghosh, S. [1 ]
Kramer, B. C. [2 ]
Gasink, C. [2 ]
Jacobstein, D. [3 ]
Adedokun, O. J. [3 ]
Gao, L. -L. [3 ]
Rutgeerts, P. [4 ]
Sands, B. E. [5 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Janssen Res & Dev LLC, Spring House, PA USA
[4] Univ Hosp Gasthuisberg, Leuven, Belgium
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.804
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P680
引用
收藏
页码：S459 / S460
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, M. T.
    Danese, S.
    Sandborn, W. J.
    Miao, Y.
    Tikhonov, I.
    Zhang, H.
    Panacciones, R.
    Hisamatsu, T.
    Scherl, E. J.
    Leong, R. W.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Afif, W.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S113 - S114
  • [22] Long-Term Efficacy of Strictureplasty for Crohn's Disease
    Uchino, Motoi
    Ikeuchi, Hiroki
    Matsuoka, Hiroki
    Matsumoto, Takayuki
    Takesue, Yoshio
    Tomita, Naohiro
    SURGERY TODAY, 2010, 40 (10) : 949 - 953
  • [23] Long-term efficacy of strictureplasty for Crohn’s disease
    Motoi Uchino
    Hiroki Ikeuchi
    Hiroki Matsuoka
    Takayuki Matsumoto
    Yoshio Takesue
    Naohiro Tomita
    Surgery Today, 2010, 40 : 949 - 953
  • [24] Long-term Efficacy of Vedolizumab for Crohn's Disease
    Vermeire, Severine
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Kaser, Arthur
    Panaccione, Remo
    Rubin, David T.
    Shafran, Ira
    McAuliffe, Megan
    Kaviya, Arpeat
    Sankoh, Serap
    Mody, Reema
    Abhyankar, Brihad
    Smyth, Michael
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 412 - 424
  • [25] CLINICAL AND ENDOSCOPIC OUTCOMES WITH USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE LONG-TERM EXTENSION PERIOD OF THE STARDUST TRIAL
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    D'Haens, Geert R.
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Bravata, Ivana
    Lavie, Frederic
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Lowenberg, Mark
    Gaya, Daniel R.
    Danese, Silvio
    GASTROENTEROLOGY, 2022, 162 (07) : S801 - S801
  • [26] Efficacy and Safety of Guselkumab for Crohn's Disease Through 3 Years: GALAXI-1 Long-Term Extension
    Afzali, Anita
    Danese, Silvio
    Panaccione, Remo
    Feagan, Brian G.
    Rubin, David T.
    Sands, Bruce E.
    Reinisch, Walter
    Panes, Julian
    Sahoo, Aparna
    Terry, Natalie A.
    Salese, Leonardo
    Corbett, Chris
    Hisamatsu, Tadakazu
    Andrews, Jane
    D'Haens, Geert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S630 - S630
  • [27] USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE UNISTAR STUDY LONG-TERM EXTENSION
    Rosh, Joel R.
    Turner, Dan
    Cohen, Stanley A.
    Griffiths, Anne M.
    Hyams, Jeffrey S.
    Kierkus, Jaroslaw
    Adedokun, Omoniyi J.
    Strauss, Richard
    Kim, Lilianne
    Volger, Sheri
    GASTROENTEROLOGY, 2023, 164 (06) : S1185 - S1185
  • [28] Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: Results from the UniStar study long-term extension
    Turner, D.
    Rosh, J. R.
    Cohen, S. A.
    Griffiths, A.
    Hyams, J. S.
    Kierkus, J.
    Adedokun, O. J.
    Strauss, R.
    Kim, L.
    Volger, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 802 - 803
  • [29] The long-term results of proctocolectomy for Crohn's disease
    Yamamoto, T
    Allan, RN
    Keighley, MRB
    GUT, 1999, 44 (02) : 296 - 296
  • [30] Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long-term extension results
    Turner, Dan
    Rosh, Joel R.
    Cohen, Stanley A.
    Griffiths, Anne M.
    Hyams, Jeffrey S.
    Kierkus, Jaroslaw
    Adedokun, Omoniyi J.
    Strauss, Richard
    Kim, Lilianne
    Volger, Sheri
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (02): : 315 - 324
12345